APA (7th ed.) Citation

Burmester, G. R., Strand, V., Kivitz, A. J., Hu, C., Wang, S., Hoogstraten, H. v., . . . Fleischmann, R. (2023). Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis. Rheumatology, 62(10), 3268. https://doi.org/10.1093/rheumatology/kead062

Chicago Style (17th ed.) Citation

Burmester, Gerd R., Vibeke Strand, Alan J. Kivitz, Chih-Chi Hu, Sheldon Wang, Hubert van Hoogstraten, Gabriella L. Klier, and Roy Fleischmann. "Long-term Safety and Efficacy of Sarilumab with or Without Background CsDMARDs in Rheumatoid Arthritis." Rheumatology 62, no. 10 (2023): 3268. https://doi.org/10.1093/rheumatology/kead062.

MLA (9th ed.) Citation

Burmester, Gerd R., et al. "Long-term Safety and Efficacy of Sarilumab with or Without Background CsDMARDs in Rheumatoid Arthritis." Rheumatology, vol. 62, no. 10, 2023, p. 3268, https://doi.org/10.1093/rheumatology/kead062.